LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

March Emerging Medical Technologies Report

Published January 2014 | 27 Pages | 30 Exhibits |


Order individually or subscribe and get a complete intel platform.


This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in March 2014. Additionally, read LSI's "Innovator of the Month" Interview with:

- Daniel Burnett, MD, President & CEO, TheraNova, LLC

All companies include technology, market(s), key executive, and contact information.

Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies

This report may be purchased separately or is automatically provided to subscribers of LSI's Emerging Medical Technologies® Database.


Table of Contents


  • A soft, flexible, bandage-like patch pump for active and simultaneous subcutaneous delivery of one or more medications, including insulin
  • A technology which involves a series of self-assembling magnets for incision-less bypass procedures within the digestive system
  • Advanced visualization technology for surgery
  • An FDA Class I, external neuro-stimulation medical device clinically shown to immediately reduce the blood pressure of hypertensive patients, via controlled cold therapy
  • An innovative infusion pump which will provide totally accurate delivery of prescribed drugs to people suffering from chronic illnesses such as diabetes and neurodegenerative diseases
  • Antimicrobial orthopedic implants for the prevention and treatment of bone-based infections
  • Biomaterials that stimulate the regeneration of bone by a novel mechanism known as osteoinductive nanoarchitecture
  • Corneal lens implant for the treatment of presbyopia, the age-related loss of the ability to read or focus on near objects
  • Diagnosis devices that measure ocular motility
  • Endoscopic vein harvesting technology
  • Hand-held device and secured web service-based platform enabling anyone anywhere to perform an accurate physical examination for remote diagnosis
  • Image-guided non-invasive brain stimulation
  • Injectable silk hydrogel for the treatment of osteoarthritis
  • Medical device technologies to improve outcomes in transcatheter aortic valve replacement procedures
  • Miniaturized implantable neuromodulation technology; lead products are directed toward a number of clinical indications including the treatment of chronic pain and overactive bladder
  • Molecular diagnostic device for the rapid detection of sepsis or other infection, to reduce unnecessary antibiotic use, and boost patient outcomes and healthcare facility efficiency
  • Molecular diagnostics test focused on detecting sepsis in critical care patients
  • Noninvasive solutions for people with sleep disordered breathing, that work by creating expiratory positive airway pressure
  • Noninvasive treatment for acute and chronic kidney disease using low frequency therapeutic ultrasound
  • One-step, point-of-care diagnostic that uses proprietary chemistry to measure enzymes to help clinicians determine how to treat chronic (or non-healing) wounds
  • Ophthalmic drug delivery technology
  • Ophthalmic surgical devices and instrumentation
  • Optical imaging technology used during cancer surgery
  • Point-of-care device that can rapidly detect and diagnose trauma-induced coagulopathy
  • Simple fluid flow control module that can be incorporated within finished medical products, such as intravenous infusion pumps, enteral feeding devices, and patient monitoring systems
  • State-of-the-art products for corneal cross-linking of corneal collagen fibers by combined riboflavin/UVA illumination for the treatment of progressive keratoconus
  • Synthetic bone substitute
  • Technologies that minimize peak skin interface pressures to prevent and expedite treatment of pressure ulcers/sores
  • Temporary cardiac pacing device to treat reversible symptomatic bradycardia
  • Wound treatment system which facilitates timely cleaning of trauma wounds such as road rash
Work with us

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.